Correction: eCF309: a potent, selective and cell-permeable mTOR inhibitor
Abstract
Correction for ‘eCF309: a potent, selective and cell-permeable mTOR inhibitor’ by Craig Fraser et al., MedChemComm, 2016, DOI: 10.1039/c5md00493d.
Maintenance work is planned from 09:00 BST to 12:00 BST on Saturday 28th September 2024.
During this time the performance of our website may be affected - searches may run slowly, some pages may be temporarily unavailable, and you may be unable to access content. If this happens, please try refreshing your web browser or try waiting two to three minutes before trying again.
We apologise for any inconvenience this might cause and thank you for your patience.
* Corresponding authors
a
Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, UK
E-mail:
Asier.Unciti-Broceta@igmm.ed.ac.uk
Correction for ‘eCF309: a potent, selective and cell-permeable mTOR inhibitor’ by Craig Fraser et al., MedChemComm, 2016, DOI: 10.1039/c5md00493d.
C. Fraser, N. O. Carragher and A. Unciti-Broceta, Med. Chem. Commun., 2016, 7, 562 DOI: 10.1039/C6MD90009G
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content